UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.535

Sortiert nach

Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China

PloS one, 2018-07, Vol.13 (7), p.e0201245-e0201245

2018

Link zum Volltext

Verfügbarkeit prüfen

Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)

PloS one, 2018-04, Vol.13 (4), p.e0193489-e0193489

2018

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity

The European journal of health economics, 2014-04, Vol.15 (3), p.253-263

2014

Link zum Volltext

Verfügbarkeit prüfen

Understanding the global measurement of willingness to pay in health

Journal of market access & health policy, 2020, Vol.8 (1), p.1717030-1717030

2020

Link zum Volltext

Verfügbarkeit prüfen

The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities

Vaccines (Basel), 2021-11, Vol.9 (11), p.1368

2021

Link zum Volltext

Verfügbarkeit prüfen

The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China

Pain and therapy, 2016-06, Vol.5 (1), p.81-91

2016

Link zum Volltext

Verfügbarkeit prüfen

Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs of Targeted Therapy-Eligible Atopic Dermatitis Patients in Taiwan—A Real-World Study

Dermatology and therapy, 2022-11, Vol.12 (11), p.2547-2562

2022

Link zum Volltext

Verfügbarkeit prüfen

Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies

Baillière's best practice & research. Clinical gastroenterology, 2013-12, Vol.27 (6), p.987-995

2013

Link zum Volltext

Verfügbarkeit prüfen

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Journal of personalized medicine, 2016-11, Vol.6 (4), p.20

2016

Link zum Volltext

Verfügbarkeit prüfen

Examining the BMI-mortality relationship using fractional polynomials

BMC medical research methodology, 2011-12, Vol.11 (1), p.175-175, Article 175

2011

Link zum Volltext

Verfügbarkeit prüfen

Ly6cLo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation

Scientific reports, 2020-04, Vol.10 (1), p.7165-7165, Article 7165

2020

Link zum Volltext

Verfügbarkeit prüfen

Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta‐thalassemia in Taiwan: A real‐world analysis

Transfusion (Philadelphia, Pa.), 2021-10, Vol.61 (10), p.2906-2917

2021

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Economic Burden of Rheumatoid Arthritis in Taiwan Using the National Health Insurance Database

Drugs -- real world outcomes, 2016-03, Vol.3 (1), p.107-114

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study

Journal of medical economics, 2019-10, Vol.22 (10), p.1006-1013

2019

Link zum Volltext

Verfügbarkeit prüfen

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

Value in health, 2015-06, Vol.18 (4), p.541-546

2015

Link zum Volltext

Verfügbarkeit prüfen

The rise of health economics and outcomes research in healthcare decision-making

Leukemia research, 2013-03, Vol.37 (3), p.238-239

Wang, Bruce C.M

2013

Link zum Volltext

Verfügbarkeit prüfen

BMI Trajectories Among the Severely Obese: Results From an Electronic Medical Record Population

Obesity (Silver Spring, Md.), 2012-10, Vol.20 (10), p.2107-2112

2012

Link zum Volltext

Verfügbarkeit prüfen

Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan

Journal of microbiology, immunology and infection, 2016-02, Vol.49 (1), p.46-51

2016

Link zum Volltext

Verfügbarkeit prüfen

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

CNS oncology, 2018-07, Vol.7 (3)

2018

Link zum Volltext

Verfügbarkeit prüfen

HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi116-vi117

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and costs of patients with ankylosing spondylitis initiating biologic therapy in taiwan – a population-based analysis

International journal of clinical rheumatology, 2021

2021

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database

Value in health regional issues, 2024-09, Vol.43, p.101007, Article 101007

2024

Link zum Volltext

Verfügbarkeit prüfen

Ly6c Lo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation

Scientific reports, 2020-04, Vol.10 (1), p.7165

2020

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life for glioblastoma short and long-term survivors receiving treatment with TTfields

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2055-2055

2021

Link zum Volltext

Verfügbarkeit prüfen

HOUT-17. ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi116-vi116

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.535

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.397)
Mit Volltextzugriff
(2.281)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.863)
Life Sciences & Biomedicine
(1.446)
Humans
(1.111)
Male
(595)
Female
(583)
Animals
(445)
Biological And Medical Sciences
(401)
Middle Aged
(346)
Medical Sciences
(305)
Aged
(292)
Physical Sciences
(290)
Adult
(287)
Mice
(234)
Neurosciences & Neurology
(189)
Science & Technology - Other Topics
(183)
Oncology
(157)
Biochemistry & Molecular Biology
(156)
Multidisciplinary Sciences
(156)
Fundamental And Applied Biological Sciences. Psychology
(153)
Technology
(153)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(41)
Cancer Research
(37)
Journal Of Medicinal Chemistry
(34)
Nature Communications
(34)
The Astronomical Journal
(34)
Chest
(33)
Proceedings Of The National Academy Of Sciences - Pnas
(32)
Nature Genetics
(31)
Blood
(29)
Nature
(29)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China

Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)

Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity

Understanding the global measurement of willingness to pay in health

The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities

The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China

Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs of Targeted Therapy-Eligible Atopic Dermatitis Patients in Taiwan—A Real-World Study

Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Examining the BMI-mortality relationship using fractional polynomials

Ly6cLo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation

Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta‐thalassemia in Taiwan: A real‐world analysis

Estimating the Economic Burden of Rheumatoid Arthritis in Taiwan Using the National Health Insurance Database

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

The rise of health economics and outcomes research in healthcare decision-making

BMI Trajectories Among the Severely Obese: Results From an Electronic Medical Record Population

Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

HOUT-18. COST EFFECTIVENESS OF TREATING GLIOBLASTOMA PATIENTS AGE 65 YEARS OR OLDER WITH TUMOR TREATING FIELDS PLUS TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE

Treatment patterns and costs of patients with ankylosing spondylitis initiating biologic therapy in taiwan – a population-based analysis

Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database

Ly6c Lo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation

Health-related quality of life for glioblastoma short and long-term survivors receiving treatment with TTfields

HOUT-17. ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE

Suchergebnisse filtern